Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
04/2003
04/23/2003EP1303506A1 6-heteroarylphenanthridines
04/23/2003EP1303499A1 Tetrazole derivatives
04/23/2003EP1303497A1 Substituted amidoalkyl-uracils as parp inhibitors
04/23/2003EP1303494A2 Potassium channel inhibitors
04/23/2003EP1303486A1 Pyrrolidine derivatives as metalloprotease inhibitors
04/23/2003EP1303485A1 Pyrrolidine derivatives as inhibitors of endothelin-converting enzyme
04/23/2003EP1303482A2 N-substituted-1-amino-1,1-dialkylcarboxylic acid derivatives
04/23/2003EP0937041B1 Use of a pharmaceutically acceptable salt of (3R,2'R)-3-[(Cyclopently-hydroxyphenylacetyl)oxy]-1,1-dimethyl-pyrrolidinium for the preparation of a medicament
04/23/2003EP0915846B1 2- and 2,5-substituted phenylketoenols
04/23/2003EP0854723B1 Substituted pyrazolyl benzenesulfonamides for use in veterinary therapies as antiinflammatory agents
04/23/2003EP0844998B1 Halobenzimidazoles and their use as microbicides
04/23/2003CN1413209A 3-(4.5-dihydroisoxazole-5-yl)-benzoylpyrazole
04/23/2003CN1413208A Novel derivatives of 3-imino-1,2,-dithioles, method for producing them and pharmaceutical compositions containing the same
04/23/2003CN1413207A 5-membered ring heterocyclic compounds with nitrogen
04/23/2003CN1413205A 2-(1H-indol-3-yl)-2-oxo-acetamides with antitumor activity
04/23/2003CN1413196A 2-Arylquinoline derivatives, preparation and therapeutic use thereof
04/23/2003CN1412181A Carboxylic acid derivative capable of inhibiting combination of integrin and its receptor
04/23/2003CN1411809A Usage and composition of pyridine onium derivative for curing application
04/23/2003CN1411800A Cosmetic composition and method
04/23/2003CN1106385C Substituted 4-benzoyl-pyrazoles
04/22/2003US6552216 Molecular model for VLA-4 inhibitors
04/22/2003US6552205 C10 OXO and hydrido taxane derivatives and pharmaceutical compositions containing them
04/22/2003US6552203 Optionally oxygenated hydrogenated thiophenes, thiopyrans and thiomorpholines containing hydroxyethylamine groups
04/22/2003US6552073 Compounds and methods of treating cell proliferative diseases
04/22/2003US6552067 EP4 receptor selective agonists in the treatment of osteoporosis
04/22/2003US6552048 Sulfonylcarboxamide derivatives, process for their preparation and their use as pharmaceuticals
04/22/2003US6552043 Benzimidazolinyl piperidines as CGRP ligands
04/22/2003US6552017 Substituted heterocycle fused gamma-carbolines
04/22/2003CA2239187C Inhibitors of farnesyl protein transferase
04/19/2003CA2361863A1 Composition and method for use of pyridinium derivatives in cosmetic and therapeutic applications
04/17/2003WO2003032072A2 Crosslinkable monomers for novel nonlinear optical polymers
04/17/2003WO2003031440A1 3,4-di-substituted maleimide compounds as cxc-chemokine receptor antagonists
04/17/2003WO2003031436A1 Heterocyclic compounds for use in the treatment of disorders of the urinary tract
04/17/2003WO2003031435A1 Pyrazole derivatives as glycine transporter inhibitors
04/17/2003WO2003031432A1 Substituted piperidines and their use for the treatment of diseases related to the histamine h3 receptor
04/17/2003WO2003031410A1 Ligands of melanocortin receptors and compositions and methods related thereto
04/17/2003WO2003031407A2 β-LACTAMYL VASOPRESSIN VlaANTAGONISTS
04/17/2003WO2003031397A1 Acylsulfonamides as inhibitors of steroid sulfatase
04/17/2003WO2003030937A1 Remedies for stress diseases comprising mitochondrial benzodiazepine receptor antagonists
04/17/2003WO2003030909A1 2- and 4-aminopyrimidines n-substtituded by a bicyclic ring for use as kinase inhibitors in the treatment of cancer
04/17/2003WO2003030902A1 Imidazole derivates as anti-inflammatory agents
04/17/2003WO2003030898A1 Modulators of ccr5 chemokine receptor activity
04/17/2003WO2003030897A1 Pyrrolidinone derivatives
04/17/2003WO2003030886A2 Allylamides useful in the treatment of alzheimer's disease
04/17/2003WO2003013484A3 N-monoacylated derivatives of o-phenylenediamines, their six membered heterocyclic analogues and their use as pharmaceutical agents
04/17/2003WO2002098852A3 Novel benzothienyl or indole derivatives, and use thereof as inhibitors of prenyl transferase proteins
04/17/2003WO2002096903A3 Chemical derivatives and the use thereof as an anti-telomerase agent
04/17/2003WO2002081735A3 Detection of negatively charged polymers using water-soluble, cationic, polythiophene derivatives
04/17/2003WO2001017965A3 Cyanopiperidines as pesticides
04/17/2003WO2000010990A3 Dicationic dibenzofuran and dibenzothiophene compounds and methods of use thereof
04/17/2003WO1999064401A3 Imidazolyl derivatives and their use as somatostatin receptor ligands
04/17/2003US20030073850 Incontinence; nasal congestion
04/17/2003US20030073849 Cyclopropylindole derivatives as selective serotonin reuptake inhibitors
04/17/2003US20030073845 Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors
04/17/2003US20030073832 Novel aminophenyl ketone derivatives
04/17/2003US20030073736 5-Substituted-3(2H)-furanones useful for inhibition of farnesyl-protein transferase
04/17/2003US20030073726 Heterocyclic inhibitors of glycine transporter 2
04/17/2003US20030073718 Enzyme inhibitors; cardiovascular disorders; antiinflammatory agents; autoimmune disease
04/17/2003US20030073709 Furans, benzofurans, and thiophenes useful in the treatment of insulin resistance and hyperglycemia
04/17/2003US20030073706 Fused thiophone derivatives and drugs containing the same as the active ingredient
04/17/2003US20030073704 Analgesics; antidiabetic agents; antiinflamamtory agents
04/17/2003US20030073692 Anticancer agents; viricides; Alzheimer's diseases
04/17/2003US20030073687 Alzheimer's disease; anticancer agents; antidiabetic agents
04/17/2003US20030073686 Anticarcinogenic agents
04/17/2003US20030073669 N-heterocyclic derivatives as NOS inhibitors
04/17/2003US20030073581 Spraying on plants, environment
04/17/2003CA2463198A1 Pyrrolidinone derivatives
04/17/2003CA2462875A1 Allylamides useful in the treatment of alzheimer's disease
04/17/2003CA2462862A1 3,4-di-substituted maleimide compounds as cxc-chemokine receptor antagonists
04/17/2003CA2458456A1 Heterocyclic compounds for use in the treatment of disorders of the urinary tract
04/17/2003CA2458453A1 Acylsulfonamides as inhibitors of steroid sulfatase
04/16/2003EP1302463A1 Medicine comprising dicyanopyridine derivative
04/16/2003EP1302462A1 Sulfone derivatives, process for their production and use thereof
04/16/2003EP1302461A1 Tnf-alpha production inhibitors
04/16/2003EP1301787A2 Method for detecting uracil biosynthesis inhibitors and their use as herbicides
04/16/2003EP1301505A2 Thiophene retinoids
04/16/2003EP1301500A1 Nitrosated and nitrosylated taxanes, compositions and methods of use
04/16/2003EP1301487A2 Viral polymerase inhibitors
04/16/2003EP1301482A1 Cyclic amine phenyl beta-3 adrenergic receptor agonists
04/16/2003EP1301481A1 Pyrrole derivatives for treating aids
04/16/2003EP1301480A1 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications
04/16/2003EP1086682B1 Utilization of aryl(or heteroaryl)azolylcarbinol derivatives in the preparation of a medicament for the treatment of neurogenic inflammation
04/16/2003EP0649414B1 Opioid diarylmethylpiperazines and piperidines
04/16/2003CN1411457A Substituted pyrroles
04/16/2003CN1411448A Pyrazole derivatives which modulate human 5-serotonin receptors
04/16/2003CN1411445A Method for preparing 3-hydroxypicolinic acid derivatives
04/16/2003CN1411440A Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
04/16/2003CN1410835A Organic photoreceptor for electronic photographing
04/16/2003CN1410834A Organic light receptor with charge transfer compound for electronic photographing
04/16/2003CN1410422A Benzfuran compound
04/16/2003CN1105717C Substituted sulphonylamino (thio) carbony/compounds
04/16/2003CN1105706C Cyclic amidino agents useful as nitric oxide synthase inhibitors
04/15/2003US6548548 Cardiovascular disorders; anticholesterol agents
04/15/2003US6548547 Sulfonylamino carboxylic acid N-arylamides as guanylate cyclase activators
04/15/2003US6548534 Hydroxy and amine or amide compounds with substitution pattern on the aryl radical; can be used alone or in combination with estrogens in contraceptive preparations for treating gynecological disorders and premenstrual symptoms
04/15/2003US6548533 Pyrrolidine carboxylic Acid or ester derivatives are useful for treating alpha 4 beta 1 mediated cell adhesion
04/15/2003US6548530 Antitumor drugs incorporate the 1,2,9,9a-tetrahydrocyclopropa(c)benz(e)indol-4-one (CBI) alkylation subunit; cytotoxic activity
04/15/2003US6548524 Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors
04/15/2003US6548499 Substituted quinoxaline derivatives as interleukin-8 receptor antagonists
04/15/2003US6548493 Substituted heterocycle fused gamma-carbolines